Vycor Medical, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US92921M2035
USD
0.09
0.02 (30.62%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Organogenesis Holdings, Inc.
Cerus Corp.
Sanara MedTech, Inc.
Pulmonx Corp.
Sight Sciences, Inc.
Utah Medical Products, Inc.
ZimVie, Inc.
CVRx, Inc.
Vycor Medical, Inc.
Butterfly Network, Inc.
AVITA Medical, Inc.

Why is Vycor Medical, Inc. ?

1
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 38.89%, its profits have risen by 18%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
9.63%
EBIT Growth (5y)
12.85%
EBIT to Interest (avg)
-0.46
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
-0.60
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.82
EV to EBIT
4.24
EV to EBITDA
4.24
EV to Capital Employed
-1.38
EV to Sales
2.23
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company
INVENTORY TURNOVER RATIO(HY)

Highest at 1.9 times

PRE-TAX PROFIT(Q)

At USD 0 MM has Grown at 125.18%

NET PROFIT(Q)

At USD 0 MM has Grown at 125.18%

-4What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at USD -0.09 MM

DEBT-EQUITY RATIO (HY)

Highest at -24.14 %

Here's what is working for Vycor Medical, Inc.

Pre-Tax Profit
At USD 0 MM has Grown at 125.18%
over average net sales of the previous four periods of USD -0.02 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
At USD 0 MM has Grown at 125.18%
over average net sales of the previous four periods of USD -0.02 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Inventory Turnover Ratio
Highest at 1.9 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for Vycor Medical, Inc.

Debt-Equity Ratio
Highest at -24.14 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Cash Flow
Lowest at USD -0.09 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)